Literature DB >> 30421103

Comparison of non-invasive assessment of arrhythmias, conduction disturbances and cardiac autonomic tone in systemic sclerosis and systemic lupus erythematosus.

Piotr Bienias1, Michał Ciurzyński2, Bartłomiej Kisiel3, Anna Chrzanowska2, Katarzyna Ciesielska2, Maria Siwicka4, Agnieszka Kalińska-Bienias5, Marek Saracyn6, Monika Lisicka2, Joanna Radochońska2, Piotr Pruszczyk2.   

Abstract

Systemic sclerosis (SSc) and systemic lupus erythematosus (SLE) are connective tissue diseases presenting cardiac complications including different arrhythmias, then direct electrocardiographic comparison may be useful in everyday clinical decision making. We examined 86 adult SSc patients, 76 with SLE and 45 healthy controls. Among other examinations all subjects underwent 24-h Holter monitoring with time-domain heart rate variability and heart rate turbulence evaluation. Patients with various co-existing conditions which might markedly influence arrhythmias and autonomic modulation were excluded from further analysis (SSc n = 12, SLE n = 6). Finally, 76 SSc and 70 SLE subjects were eligible for this study, mean age 51.9 ± 13.1 and 46.5 ± 12.7 years (p = 0.11), with median disease duration 6.0 and 8.5 years (p = 0.15), respectively. As compared to SLE, patients with SSc were characterised by more frequent incidence of various supraventricular and ventricular arrhythmias. As compared to SSc, patients with SLE presented prolonged corrected QT intervals and also significant correlations between corrected QT length and heart rate variability indices. Both SSc and SLE subjects presented impaired sympathetic cardiac autonomic modulation, while indices associated with parasympathetic activity in SLE were not diminished. Disease duration was not associated with arrhythmias' occurrence (except for ventricular tachycardia in SSc, p = 0.02) and also with autonomic function in both groups of patients. Patients with SSc and SLE differ in terms of arrhythmias, conduction disturbances and cardiac autonomic tone. Regular Holter monitoring should be considered as a part of routine evaluation in connective tissue diseases patients, especially in systemic sclerosis.

Entities:  

Keywords:  Arrhythmias; Cardiac autonomic dysfunction; Conduction disturbances; Heart rate turbulence; Heart rate variability; Systemic lupus erythematosus; Systemic sclerosis

Mesh:

Year:  2018        PMID: 30421103     DOI: 10.1007/s00296-018-4207-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  36 in total

1.  Heart rate turbulence impairment and ventricular arrhythmias in patients with systemic sclerosis.

Authors:  Piotr Bienias; Michał Ciurzyński; Maria Glińska-Wielochowska; Dariusz Korczak; Agnieszka Kalińska-Bienias; Wiesław Gliński; Piotr Pruszczyk
Journal:  Pacing Clin Electrophysiol       Date:  2010-04-27       Impact factor: 1.976

2.  The effect of metoprolol alone and combined metoprolol-felodipin on the digital microcirculation of patients with primary Raynaud's syndrome.

Authors:  Zoltan Csiki; Ildiko Garai; Amir H Shemirani; Gabor Papp; Katalin S Zsori; Csilla Andras; Margit Zeher
Journal:  Microvasc Res       Date:  2011-04-15       Impact factor: 3.514

Review 3.  Mortality and survival in systemic sclerosis: systematic review and meta-analysis.

Authors:  Manuel Rubio-Rivas; Cristina Royo; Carmen Pilar Simeón; Xavier Corbella; Vicent Fonollosa
Journal:  Semin Arthritis Rheum       Date:  2014-05-14       Impact factor: 5.532

4.  Evidence for cardiac safety and antiarrhythmic potential of chloroquine in systemic lupus erythematosus.

Authors:  Ricardo Alkmim Teixeira; Eduardo F Borba; Anísio Pedrosa; Silvana Nishioka; Vilma S T Viana; José A Ramires; Roberto Kalil-Filho; Eloísa Bonfá; Martino Martinelli Filho
Journal:  Europace       Date:  2013-09-19       Impact factor: 5.214

5.  2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry.

Authors:  Jonathan S Steinberg; Niraj Varma; Iwona Cygankiewicz; Peter Aziz; Paweł Balsam; Adrian Baranchuk; Daniel J Cantillon; Polychronis Dilaveris; Sergio J Dubner; Nabil El-Sherif; Jaroslaw Krol; Malgorzata Kurpesa; Maria Teresa La Rovere; Suave S Lobodzinski; Emanuela T Locati; Suneet Mittal; Brian Olshansky; Ewa Piotrowicz; Leslie Saxon; Peter H Stone; Larisa Tereshchenko; Mintu P Turakhia; Gioia Turitto; Neil J Wimmer; Richard L Verrier; Wojciech Zareba; Ryszard Piotrowicz
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-05       Impact factor: 1.468

6.  Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block.

Authors:  Marta Tonello; Ariela Hoxha; Elena Mattia; Alessandra Zambon; Silvia Visentin; Alessia Cerutti; Anna Ghirardello; Ornella Milanesi; Amelia Ruffatti
Journal:  Clin Rheumatol       Date:  2017-02-15       Impact factor: 2.980

7.  2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Ann Rheum Dis       Date:  2013-11       Impact factor: 19.103

Review 8.  Heart rate variability in patients with systemic lupus erythematosus: a systematic review and methodological considerations.

Authors:  P S Matusik; P T Matusik; P K Stein
Journal:  Lupus       Date:  2018-04-26       Impact factor: 2.911

9.  ECG non-specific ST-T and QTc abnormalities in patients with systemic lupus erythematosus compared with rheumatoid arthritis.

Authors:  Laura Geraldino-Pardilla; Yevgeniya Gartshteyn; Paloma Piña; Marina Cerrone; Jon T Giles; Afshin Zartoshti; Joan M Bathon; Anca D Askanase
Journal:  Lupus Sci Med       Date:  2016-12-16

Review 10.  Primary myocardial disease in scleroderma-a comprehensive review of the literature to inform the UK Systemic Sclerosis Study Group cardiac working group.

Authors:  Lesley-Anne Bissell; Md Yuzaiful Md Yusof; Maya H Buch
Journal:  Rheumatology (Oxford)       Date:  2017-06-01       Impact factor: 7.580

View more
  4 in total

1.  Peak strain dispersion within the left ventricle detected by two-dimensional speckle tracking in patients with uncomplicated systemic lupus erythematosus.

Authors:  Chunmei Li; Kun Li; Miao Yuan; Wenjuan Bai; Li Rao
Journal:  Int J Cardiovasc Imaging       Date:  2021-03-04       Impact factor: 2.357

2.  Prognostic Value of Cardiac Axis Deviation in Systemic Sclerosis-Related Pulmonary Hypertension.

Authors:  Justin K Lui; Ruchika A Sangani; Clara A Chen; Andreea M Bujor; Marcin A Trojanowski; Deepa M Gopal; Michael P LaValley; Renda Soylemez Wiener; Elizabeth S Klings
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-04-05       Impact factor: 5.178

3.  Cardiopulmonary exercise testing in a combined screening approach to individuate pulmonary arterial hypertension in systemic sclerosis.

Authors:  Alessandro Santaniello; Rosa Casella; Marco Vicenzi; Irene Rota; Gaia Montanelli; Maria De Santis; Chiara Bellocchi; Federico Lombardi; Lorenzo Beretta
Journal:  Rheumatology (Oxford)       Date:  2020-07-01       Impact factor: 7.580

4.  Electrocardiographic markers for the prediction of ventricular arrhythmias in patients with systemic sclerosis.

Authors:  Veronika Sebestyén; Gabriella Szűcs; Dénes Páll; Dóra Ujvárosy; Tamás Ötvös; Imre Csige; Tamás Pataki; István Lőrincz; Zoltán Szabó
Journal:  Rheumatology (Oxford)       Date:  2020-03-01       Impact factor: 7.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.